Dr. Robert G. Perry, MD

Dr. Perry practices at Rgpmd in Pembroke Pines, Florida.

Dr. Perry's NPI, 1831245554, was assigned on January 26, 2007. Dr. Perry graduated from St. George's University School of Medicine in 1999. Dr. Perry holds Florida license ME94381.

Dr. Perry's primary practice is Rgpmd, at 2250 Nw 136th Ave, Pembroke Pines, FL 33028. The practice phone is (954) 302-7960.

Dr. Perry's primary practice is Rgpmd in Pembroke Pines, Florida. Dr. Perry is also affiliated with Memorial Hospital West. The medical group on file is RGPMD Health and Wellness. Dmand AI also links Dr. Perry to 3 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perry practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Perry's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Perry is board certified in internal medicine by the National Board of Physicians and Surgeons. Dmand AI has Dr. Perry's licenses on file in 3 states: Florida, New York and Arizona.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, alzheimer's disease, arthritis, asthma, bursitis and carpal tunnel syndrome among the conditions Dr. Perry treats.

CMS data shows 795 Medicare services from Dr. Perry across 6 procedure codes in 2024, for 276 Medicare patients. Medicare paid $73,267 for them. Every service was in an office.

CMS counts 276 Medicare patients who saw Dr. Perry in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Perry's median patient age at 56, with 54% women.

In 2024, Dr. Perry wrote 3,647 Medicare Part D claims for 428 patients. 85% of them were for generic drugs. CMS names the drug for 2,851 of them, across 73 drugs with 11 or more claims each, at $261,515 in total drug cost. In 2023, CMS named 3,991 claims across 95 drugs.

CMS lists Dr. Perry as offering telehealth.

Dmand AI links 11 papers to Dr. Perry, published from 2015 to 2021. 2017 was the busiest year, with 3. The most frequent topics are Double-Blind Method, Antibodies, Monoclonal, Humanized and Azetidines. Dr. Perry has published most often in JAMA Netw Open. Dr. Perry's most frequent co-authors are Ronenn Roubenoff, MD, MHS, Thomas Crawford Marbury, MD and Ram Ron Miller, MD.

Dmand AI links Dr. Perry to 7 clinical trials. 2 are still active or recruiting. Conditions studied include COVID-19, Pneumonia, Viral and Diabetes Mellitus, Type 2. Eli Lilly and Company sponsors the most, 6. Open Payments lists research payments to Dr. Perry that name 5 trials.

CMS Open Payments shows 621 general payments to Dr. Perry from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Novo Nordisk Inc paid the most, $2,468. It also lists 8 research payments totaling $20,781 from 2020 to 2024, naming 5 clinical trials.

Dmand AI lists 1 award for Dr. Perry, most recently CMS Stage 1 EHR in 2012.

Dr. Perry graduated from St. George's University School of Medicine in 1999.

Dr. Perry is in network with 11 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.